DE60213219D1 - Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten - Google Patents
Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheitenInfo
- Publication number
- DE60213219D1 DE60213219D1 DE60213219T DE60213219T DE60213219D1 DE 60213219 D1 DE60213219 D1 DE 60213219D1 DE 60213219 T DE60213219 T DE 60213219T DE 60213219 T DE60213219 T DE 60213219T DE 60213219 D1 DE60213219 D1 DE 60213219D1
- Authority
- DE
- Germany
- Prior art keywords
- medicament
- derivatives
- treatment
- dioxide
- thiolutine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105959A EP1238668A1 (de) | 2001-03-09 | 2001-03-09 | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten und verfahren zu ihrer herstellung |
| PCT/EP2002/001915 WO2002072089A2 (en) | 2001-03-09 | 2002-02-23 | Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60213219D1 true DE60213219D1 (de) | 2006-08-31 |
Family
ID=8176735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60213219T Expired - Lifetime DE60213219D1 (de) | 2001-03-09 | 2002-02-23 | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020193418A1 (de) |
| EP (2) | EP1238668A1 (de) |
| JP (1) | JP2004521927A (de) |
| KR (1) | KR20040025902A (de) |
| CN (1) | CN1279906C (de) |
| AT (1) | ATE333276T1 (de) |
| AU (1) | AU2002250997B2 (de) |
| BG (1) | BG108161A (de) |
| BR (1) | BR0207884A (de) |
| CA (1) | CA2439853A1 (de) |
| CZ (1) | CZ20032427A3 (de) |
| DE (1) | DE60213219D1 (de) |
| EE (1) | EE200300430A (de) |
| HR (1) | HRP20030714A2 (de) |
| IL (1) | IL157792A0 (de) |
| MX (1) | MXPA03007551A (de) |
| NO (1) | NO20033964L (de) |
| NZ (1) | NZ528071A (de) |
| PL (1) | PL363374A1 (de) |
| RU (1) | RU2003129889A (de) |
| SK (1) | SK11202003A3 (de) |
| WO (1) | WO2002072089A2 (de) |
| YU (1) | YU68403A (de) |
| ZA (1) | ZA200306474B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108371661B (zh) * | 2018-01-19 | 2019-03-19 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用 |
| CN113209088B (zh) * | 2021-03-11 | 2022-03-22 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用 |
| CN115261422A (zh) * | 2022-06-30 | 2022-11-01 | 塔里木大学 | 一种新物种来源硫藤黄菌素的制备方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996032396A1 (en) * | 1995-04-11 | 1996-10-17 | John Malcolm Webster | Xenorxides with antibacterial and antimycotic properties |
| CA2212237A1 (en) * | 1997-09-05 | 1999-03-05 | John M. Webster | Novel antineoplastic agents |
-
2001
- 2001-03-09 EP EP01105959A patent/EP1238668A1/de not_active Withdrawn
-
2002
- 2002-02-23 IL IL15779202A patent/IL157792A0/xx unknown
- 2002-02-23 BR BR0207884-8A patent/BR0207884A/pt not_active IP Right Cessation
- 2002-02-23 DE DE60213219T patent/DE60213219D1/de not_active Expired - Lifetime
- 2002-02-23 AU AU2002250997A patent/AU2002250997B2/en not_active Ceased
- 2002-02-23 EP EP02719902A patent/EP1372640B1/de not_active Expired - Lifetime
- 2002-02-23 CN CNB028079493A patent/CN1279906C/zh not_active Expired - Fee Related
- 2002-02-23 AT AT02719902T patent/ATE333276T1/de not_active IP Right Cessation
- 2002-02-23 CA CA002439853A patent/CA2439853A1/en not_active Abandoned
- 2002-02-23 MX MXPA03007551A patent/MXPA03007551A/es unknown
- 2002-02-23 EE EEP200300430A patent/EE200300430A/xx unknown
- 2002-02-23 RU RU2003129889/15A patent/RU2003129889A/ru not_active Application Discontinuation
- 2002-02-23 PL PL02363374A patent/PL363374A1/xx unknown
- 2002-02-23 CZ CZ20032427A patent/CZ20032427A3/cs unknown
- 2002-02-23 WO PCT/EP2002/001915 patent/WO2002072089A2/en not_active Application Discontinuation
- 2002-02-23 SK SK1120-2003A patent/SK11202003A3/sk unknown
- 2002-02-23 NZ NZ528071A patent/NZ528071A/en unknown
- 2002-02-23 KR KR10-2003-7011817A patent/KR20040025902A/ko not_active Application Discontinuation
- 2002-02-23 JP JP2002571048A patent/JP2004521927A/ja not_active Abandoned
- 2002-02-23 YU YU68403A patent/YU68403A/sh unknown
- 2002-03-08 US US10/092,882 patent/US20020193418A1/en not_active Abandoned
-
2003
- 2003-08-20 ZA ZA200306474A patent/ZA200306474B/en unknown
- 2003-09-08 HR HR20030714A patent/HRP20030714A2/xx not_active Application Discontinuation
- 2003-09-08 BG BG108161A patent/BG108161A/xx unknown
- 2003-09-08 NO NO20033964A patent/NO20033964L/no unknown
-
2004
- 2004-10-26 US US10/973,309 patent/US20050059725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20032427A3 (cs) | 2004-01-14 |
| ZA200306474B (en) | 2004-04-29 |
| IL157792A0 (en) | 2004-03-28 |
| CA2439853A1 (en) | 2002-09-19 |
| NO20033964D0 (no) | 2003-09-08 |
| PL363374A1 (en) | 2004-11-15 |
| HRP20030714A2 (en) | 2005-04-30 |
| WO2002072089A3 (en) | 2002-11-14 |
| JP2004521927A (ja) | 2004-07-22 |
| KR20040025902A (ko) | 2004-03-26 |
| WO2002072089A2 (en) | 2002-09-19 |
| EP1238668A1 (de) | 2002-09-11 |
| US20020193418A1 (en) | 2002-12-19 |
| MXPA03007551A (es) | 2003-12-04 |
| EP1372640A2 (de) | 2004-01-02 |
| BR0207884A (pt) | 2004-07-27 |
| BG108161A (en) | 2004-09-30 |
| NZ528071A (en) | 2005-02-25 |
| RU2003129889A (ru) | 2005-03-10 |
| AU2002250997B2 (en) | 2006-03-09 |
| SK11202003A3 (sk) | 2004-02-03 |
| CN1501800A (zh) | 2004-06-02 |
| CN1279906C (zh) | 2006-10-18 |
| ATE333276T1 (de) | 2006-08-15 |
| NO20033964L (no) | 2003-09-08 |
| US20050059725A1 (en) | 2005-03-17 |
| EE200300430A (et) | 2003-12-15 |
| YU68403A (sh) | 2006-08-17 |
| EP1372640B1 (de) | 2006-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE342964T1 (de) | Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen | |
| DE60144123D1 (de) | Verfahren zur Behandlung von Arzneimittelinduzierter peripherer Neuropathie und verwandten Krankheitsformen | |
| ATE427114T1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen | |
| HK1083624A1 (en) | Hydroxyethylamine derivatives for the treatment ofalzheimer's disease | |
| DE69634301D1 (de) | Methode zur behandlung von alzheimer mit einem von einer gliazelllinie stammenden neurotrophen protein (gdnf) | |
| ATE492279T1 (de) | Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen | |
| DE60221283D1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| ATE293976T1 (de) | Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen | |
| GB0328900D0 (en) | Novel compounds | |
| ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
| DE60213219D1 (de) | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten | |
| ATE388719T1 (de) | Verwendung von feigenkaktus (opuntia) zur herstellung eines medikaments zur behandlung von depressionen | |
| ATE334680T1 (de) | 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel | |
| ATE408602T1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| DE68903907D1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
| PT1255734E (pt) | Derivados de isatina com actividade neurotrofica | |
| ATE334124T1 (de) | Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist | |
| ATE359995T1 (de) | Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| MXPA04001951A (es) | Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos. | |
| DE50102262D1 (de) | Verwendung von 2-methyl-thiazolidin 2,4-dicarbonsäure zur herstellung eines medikaments zur behandlung von infektionskrankheiten | |
| ATE300304T1 (de) | Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |